United States · FDA National Drug Code directory

Levothyroxine Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
67046-1612_4302e10f-7a8b-1b53-e063-6294a90abfc0
Product NDC
67046-1612
Form
TABLET
Composition / generic term
Levothyroxine Sodium
Labeler
Coupler LLC
Marketing category
NDA AUTHORIZED GENERIC
Marketing start / end (source format)
20251107
Source listing expiry
20261231

Source-listed ingredients

  • LEVOTHYROXINE SODIUM — 125 ug/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BLISTER PACK (67046-1612-3) · 67046-1612-3

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →